
BUPROCARE 2MG TABLET
Marketer
Gentech Healthcare Pvt Ltd
Salt Composition
Buprenorphine (2mg)
Overview BUPROCARE 2MG TABLET
Buprenorphine 2mg tablets (BUPROCARE) are indicated for managing opioid (e.g., morphine) addiction. This medication mitigates withdrawal symptoms associated with opioid cessation. Successful treatment often incorporates comprehensive support, including therapy and lifestyle adjustments. Prescription is limited to patients aged 16 and older. As a potentially habit-forming medication, strict adherence to the physician's instructions is crucial. Treatment may involve additional social and psychological interventions. It can be administered with or without food. Consistent daily use, as directed by your doctor, is essential for efficacy; missed doses reduce effectiveness. Common adverse reactions include fatigue, opioid withdrawal symptoms, unease, jitteriness, lightheadedness, cephalgia, somnolence, bowel looseness, nausea, emesis, and stomach discomfort. Persistent or worsening side effects warrant immediate medical attention; your doctor can offer management strategies. Prior to commencing treatment, disclose any pre-existing health issues or medications to your physician to ensure safety. This is especially important for pregnant and breastfeeding individuals, who must seek medical counsel before use.
Uses of BUPROCARE 2MG TABLET
Morphine addiction; Treatment of significant to intense pain
Major Benefits of BUPROCARE 2MG TABLET:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the 2mg BUPROCARE tablet whole; avoid chewing, crushing, or fracturing. Consumption with or without food is acceptable; however, consistent timing is recommended.
Common Side effects of BUPROCARE 2MG TABLET:
- Headache
- Drug withdrawal syndrome
- Back pain
- Drowsiness
- Vomiting
- Insomnia (difficulty in sleeping)
- Dizziness
- Abdominal pain
- Weakness
- Sleepiness
- Sweating
- Constipation
- Withdrawal syndrome
- Infection
- Vertigo
- Inflammation of the nose
- Chills
- Flu-like symptoms
- Nausea
How to use BUPROCARE 2MG TABLET:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and schedule. Ingest the 2mg BUPROCARE tablet whole; avoid chewing, crushing, or fracturing it. While it can be taken with or without food, consistent timing is recommended for optimal efficacy.
How BUPROCARE 2MG TABLET works:
Suboxone 2mg tablets function as a partial opioid agonist, mitigating withdrawal symptoms in individuals ceasing opioid use by mimicking the effects of opioids.
SAFETY ADVICE
AlcoholUNSAFE
Combining BUPROCARE 2MG TABLETS with alcohol is dangerous.
PregnancyCONSULT YOUR DOCTOR
Using BUPROCARE 2MG TABLETS during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the benefits against potential risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of BUPROCARE 2MG TABLETS while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking a BUPROCARE 2MG TABLET may cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with severe kidney impairment should use BUPROCARE 2MG TABLETS cautiously; dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Caution is advised when administering Buprocare 2mg tablets to individuals with hepatic impairment; dosage modification may be necessary. Physician consultation is recommended. Buprocare 2mg tablets are contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take BUPROCARE 2MG TABLET :
NA
Facts to Know About BUPROCARE 2MG TABLET
| Label | Value |
|---|---|
| Chemical Type | Phenanthrene Derivatives |
| Developing Habits | Affirmative. |
| Treatment Category | Neuroscience Central Nervous System |
| Actions | Partial Opioid Agonists |
